John Alexander's Insider Trades & SAST Disclosures
John Alexander's most recent trade in Diageo plc - ADR was a trade of 299 Ords 0.29p done at an average price of $21.9 . Disclosure was reported to the exchange on May 12, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern John Alexander.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Diageo plc - ADR | John Alexander Manzoni | Non-Executive Director,Chairman | Purchase of securities on an exchange or from another person at price $ 21.94 per share. | 12 May 2025 | 299 | 3,973 (0%) | 0% | 21.9 | 6,560 | Ords 0.29p |
| Uber Technologies Inc | John Alexander Thain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2025 | 4,091 | 4,091 | - | - | Restricted Stock Units | |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2025 | 3,782 | 181,611 (0%) | 0% | - | Common Stock | |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2025 | 3,782 | 0 | - | - | Restricted Stock Units | |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2025 | 302 | 177,829 (0%) | 0% | - | Common Stock | |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2025 | 302 | 0 | - | - | Restricted Stock Units | |
| Diageo plc - ADR | John Alexander Manzoni | Non-Executive Director,Chairman | Purchase of securities on an exchange or from another person at price $ 20.79 per share. | 10 Apr 2025 | 315 | 3,674 (0%) | 0% | 20.8 | 6,549 | Ords 0.29p |
| Uber Technologies Inc | John Alexander Thain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 302 | 302 | - | - | Restricted Stock Units | |
| Ambarella Inc | John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 55.02 per share. | 18 Mar 2025 | 2,103 | 113,886 (0%) | 0% | 55.0 | 115,707 | Ordinary Shares |
| Diageo plc - ADR | John Alexander Manzoni | Non-Executive Director,Chairman | Purchase of securities on an exchange or from another person at price $ 21.92 per share. | 10 Mar 2025 | 299 | 3,359 (0%) | 0% | 21.9 | 6,554 | Ords 0.29p |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 1,702 | 0 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2025 | 1,702 | 86,256 (0%) | 0% | - | Common Stock | |
| Ambarella Inc | John Alexander Young | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 12,388 | 113,781 (0%) | 0% | 0 | Ordinary Shares | |
| Ambarella Inc | John Alexander Young | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 12,388 | 12,388 | - | - | Performance Stock Units | |
| Ambarella Inc | John Alexander Young | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,637 | 118,418 (0%) | 0% | 0 | Ordinary Shares | |
| Ambarella Inc | John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 55.11 per share. | 28 Feb 2025 | 2,663 | 115,755 (0%) | 0% | 55.1 | 146,758 | Ordinary Shares |
| KBR Inc | John Alexander Manzoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 3,521 | 13,243 (0%) | 0% | 0 | Common Stock | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 44,368 | 84,554 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 26,575 | 53,150 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 13,904 | 27,801 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2025 | 3,889 | 3,888 | - | - | Restricted Stock Units | |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 358 | 177,527 (0%) | 0% | - | Common Stock | |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jan 2025 | 358 | 0 | - | - | Restricted Stock Units | |
| Uber Technologies Inc | John Alexander Thain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 358 | 358 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Kelly Alexander | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.75 per share. | 27 Dec 2024 | 2,113 | 40,186 (0%) | 0% | 4.8 | 10,037 | Common Stock |
| Ambarella Inc | Alexander John Young | CFO | Sale of securities on an exchange or to another person at price $ 75.41 per share. | 16 Dec 2024 | 2,136 | 101,393 (0%) | 0% | 75.4 | 161,076 | Ordinary Shares |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 6.76 per share. | 21 Nov 2024 | 3,000 | 38,073 (0%) | 0% | 6.8 | 20,280 | Common Stock |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2024 | 3,605 | 3,605 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2024 | 3,605 | 35,073 (0%) | 0% | - | Common Stock | |
| Diageo plc - ADR | John Alexander Manzoni | Non-Executive Director | Sale or transfer of securities back to the company at price $ 26.21 per share. | 21 Oct 2024 | 53 | 3,060 (0%) | 0% | 26.2 | 1,389 | Ords 0.29p |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 312 | 0 | - | - | Restricted Stock Units | |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Oct 2024 | 312 | 177,169 (0%) | 0% | - | Common Stock | |
| Uber Technologies Inc | John Alexander Thain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Oct 2024 | 312 | 312 | - | - | Restricted Stock Units | |
| Ambarella Inc | John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 53.54 per share. | 17 Sep 2024 | 2,139 | 103,529 (0%) | 0% | 53.5 | 114,522 | Ordinary Shares |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2024 | 79,725 | 79,725 | - | - | Restricted Stock Units | |
| Caredx Inc | Alexander L. Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 33.17 per share. | 20 Aug 2024 | 39,466 | 284,983 (0%) | 0% | 33.2 | 1,309,087 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.48 per share. | 20 Aug 2024 | 39,466 | 324,449 (0%) | 0% | 23.5 | 926,662 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 39,466 | 71,126 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Alexander L. Johnson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Aug 2024 | 21,557 | 49,569 | - | - | Employee Stock Option (right to buy) | |
| Caredx Inc | Alexander L. Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 32.58 per share. | 20 Aug 2024 | 21,557 | 284,983 (0%) | 0% | 32.6 | 702,327 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.48 per share. | 20 Aug 2024 | 21,557 | 306,540 (0%) | 0% | 23.5 | 506,158 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 33.52 per share. | 19 Aug 2024 | 23,548 | 284,983 (0%) | 0% | 33.5 | 789,329 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 33.53 per share. | 19 Aug 2024 | 8,000 | 311,214 (0%) | 0% | 33.5 | 268,240 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Sale of securities on an exchange or to another person at price $ 33.83 per share. | 19 Aug 2024 | 2,683 | 308,531 (0%) | 0% | 33.8 | 90,766 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.58 per share. | 01 Aug 2024 | 7,371 | 319,214 (0%) | 0% | 23.6 | 173,808 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.09 per share. | 19 Jul 2024 | 1,690 | 326,585 (0%) | 0% | 18.1 | 30,572 | Common Stock |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 323 | 176,857 (0%) | 0% | - | Common Stock | |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jul 2024 | 323 | 0 | - | - | Restricted Stock Units | |
| Uber Technologies Inc | John Alexander Thain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jul 2024 | 323 | 323 | - | - | Restricted Stock Units | |
| Caredx Inc | Alexander L. Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.59 per share. | 08 Jul 2024 | 634 | 328,275 (0%) | 0% | 15.6 | 9,884 | Common Stock |
| Ambarella Inc | John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 55.48 per share. | 18 Jun 2024 | 2,157 | 105,414 (0%) | 0% | 55.5 | 119,670 | Ordinary Shares |
| Caredx Inc | Alexander L. Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.54 per share. | 17 Jun 2024 | 9,253 | 328,909 (0%) | 0% | 13.5 | 125,286 | Common Stock |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 454 | 31,468 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 454 | 0 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 12.00 per share. | 08 May 2024 | 8,334 | 31,014 (0%) | 0% | 12 | 100,008 | Common Stock |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2024 | 8,850 | 176,534 (0%) | 0% | - | Common Stock | |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 May 2024 | 8,850 | 0 | - | - | Restricted Stock Units | |
| Uber Technologies Inc | John Alexander Thain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2024 | 3,782 | 3,782 | - | - | Restricted Stock Units | |
| Caredx Inc | Alexander L. Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.18 per share. | 01 May 2024 | 7,371 | 338,162 (0%) | 0% | 9.2 | 67,666 | Common Stock |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Apr 2024 | 41,705 | 41,705 | - | - | Restricted Stock Units | |
| Diageo plc - ADR | John Alexander Manzoni | Non-Executive Director | Sale or transfer of securities back to the company at price $ 27.79 per share. | 17 Apr 2024 | 33 | 3,007 (0%) | 0% | 27.8 | 917 | Ords 0.29p |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 286 | 167,684 (0%) | 0% | - | Common Stock | |
| Uber Technologies Inc | John Alexander Thain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2024 | 286 | 0 | - | - | Restricted Stock Units | |
| Uber Technologies Inc | John Alexander Thain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2024 | 286 | 286 | - | - | Restricted Stock Units | |
| Essa Pharma Inc | John Alexander Martin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 50,000 | 50,000 | - | - | Options | |
| Ambarella Inc | John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 49.27 per share. | 18 Mar 2024 | 1,546 | 107,571 (0%) | 0% | 49.3 | 76,171 | Ordinary Shares |
| Ambarella Inc | John Alexander Young | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 1,176 | 109,603 (0%) | 0% | 0 | Ordinary Shares | |
| Ambarella Inc | John Alexander Young | CFO | Sale of securities on an exchange or to another person at price $ 57.16 per share. | 07 Mar 2024 | 704 | 108,899 (0%) | 0% | 57.2 | 40,241 | Ordinary Shares |
| Ambarella Inc | John Alexander Young | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 16,845 | 108,427 (0%) | 0% | 0 | Ordinary Shares | |
| Ambarella Inc | John Alexander Young | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Feb 2024 | 16,845 | 16,845 | - | - | Performance Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1,702 | 1,702 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Feb 2024 | 1,702 | 22,680 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 18.50 per share. | 29 Feb 2024 | 506 | 20,978 (0%) | 0% | 18.5 | 9,361 | Common Stock |
| KBR Inc | Alexander John Manzoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2024 | 2,868 | 9,722 (0%) | 0% | 0 | Common Stock | |
| Caredx Inc | L. Alexander Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.56 per share. | 05 Feb 2024 | 1,120 | 169,893 (0%) | 0% | 8.6 | 9,587 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 174,520 | 345,533 (0%) | 0% | 0 | Common Stock | |
| Caredx Inc | L. Alexander Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.88 per share. | 01 Feb 2024 | 11,245 | 175,179 (0%) | 0% | 8.9 | 99,856 | Common Stock |
| Caredx Inc | Johnson L. Alexander | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.72 per share. | 01 Feb 2024 | 2,552 | 171,013 (0%) | 0% | 8.7 | 22,253 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.72 per share. | 01 Feb 2024 | 1,614 | 173,565 (0%) | 0% | 8.7 | 14,074 | Common Stock |
| Caredx Inc | Alexander L. Johnson | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.88 per share. | 29 Jan 2024 | 1,120 | 186,424 (0%) | 0% | 9.9 | 11,066 | Common Stock |
| Precision Biosciences Inc | Kelly John Alexander | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2024 | 116,690 | 233,310 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | Kelly John Alexander | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2024 | 116,690 | 614,169 (1%) | 0% | - | Common Stock | |
| Caredx Inc | Alexander Johnson L. | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.94 per share. | 02 Jan 2024 | 1,047 | 187,544 (0%) | 0% | 11.9 | 12,501 | Common Stock |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.48 per share. | 18 Aug 2023 | 90,000 | 383,340 (0%) | 0% | 0.5 | 43,200 | Common Stock |
| Caredx Inc | Alexander L. Johnson | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.80 per share. | 07 Aug 2023 | 217 | 188,591 (0%) | 0% | 10.8 | 2,344 | Common Stock |
| Caredx Inc | Alexander L. Johnson | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.28 per share. | 19 Jul 2023 | 1,163 | 188,808 (0%) | 0% | 10.3 | 11,956 | Common Stock |
| Caredx Inc | Alexander L. Johnson | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.37 per share. | 06 Jul 2023 | 422 | 189,971 (0%) | 0% | 8.4 | 3,532 | Common Stock |
| Caredx Inc | Alexander L. Johnson | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.96 per share. | 16 Jun 2023 | 6,343 | 190,393 (0%) | 0% | 8.0 | 50,490 | Common Stock |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 34,091 | 0 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 34,091 | 279,705 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 13,635 | 293,340 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 13,635 | 13,635 | - | - | Restricted Stock Units | |
| Caredx Inc | Alexander L. Johnson | Chief Business Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.98 per share. | 05 Jun 2023 | 433 | 196,736 (0%) | 0% | 8.0 | 3,455 | Common Stock |
| KBR Inc | John Alexander Manzoni | Director | Grant, award, or other acquisition of securities at price $ 59.43 per share. | 17 Apr 2023 | 7 | 6,854 (0%) | 0% | 59.4 | 416 | Common Stock |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.86 per share. | 17 Mar 2023 | 20,000 | 245,614 (0%) | 0% | 0.9 | 17,200 | Common Stock |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 51,071 | 225,614 (0%) | 0% | - | Common Stock | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2023 | 51,071 | 102,114 | - | - | Restricted Stock Units | |
| Precision Biosciences Inc | John Alexander Kelly | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.95 per share. | 28 Feb 2023 | 11,605 | 174,543 (0%) | 0% | 1.0 | 11,025 | Common Stock |
| KBR Inc | John Alexander Manzoni | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2023 | 3,053 | 6,847 (0%) | 0% | 0 | Common Stock | |
| Caredx Inc | Alexander L. Johnson | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 85,100 | 197,450 (0%) | 0% | 0 | Common Stock | |
| Caredx Inc | Alexander L. Johnson | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 44,100 | 44,100 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges